Proxy Votes Now

Home › Funds › JANUS INVESTMENT FUND › Janus Henderson Global Life Sciences Fund

Janus Henderson Global Life Sciences Fund (JAGLX) proxy voting record 2025-2026

Fund family: JANUS INVESTMENT FUND · Filed by JANUS INVESTMENT FUND (CIK 277751) · SEC series S000010494

Share classes and tickers: JAGLX (C000028956), JFNAX (C000077752), JFNCX (C000077753), JFNIX (C000077754), JFNNX (C000198286), JFNSX (C000077755), JNGLX (C000083538)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 780 with, 21 against, 0 abstentions (not counted as with management). Shareholder proposals: 10 FOR, 11 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with JANUS INVESTMENT FUND as a whole

The same two figures as JANUS INVESTMENT FUND’s manager page (17,858 ballot items across 30 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsJANUS INVESTMENT FUNDItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)98.8%74597.2%15,061
Backed environmental and social shareholder proposals at US companiesn/a83.6%392

Where this fund voted differently from most JANUS INVESTMENT FUND funds

Each ballot item this fund voted is set against the votes of the other JANUS INVESTMENT FUND funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most JANUS INVESTMENT FUND funds on 6 items (2.0% of the 305 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost JANUS INVESTMENT FUND fundsMgmtResult
Danaher Corporation2026-05-05To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: A. Shane SandersAgainstFOR — 5 of 5 JANUS INVESTMENT FUND fundsAgainstElected, 73.8% support
Danaher Corporation2026-05-05To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Raymond C. Stevens, Ph.D.AgainstFOR — 5 of 5 JANUS INVESTMENT FUND fundsAgainstElected, 79.7% support
Danaher Corporation2026-05-05To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Teri L. ListAgainstFOR — 5 of 5 JANUS INVESTMENT FUND fundsAgainstElected, 77.7% support
HCA Healthcare, Inc.2026-04-23Shareholder Stockholder proposal, if properly presented at the meeting, regarding stockholders' right to act by written consent.ForAGAINST — 3 of 3 JANUS INVESTMENT FUND fundsAgainstNot approved, 22.0% support
Eli Lilly and Company2026-05-04Shareholder Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair.AgainstFOR — 6 of 8 JANUS INVESTMENT FUND fundsForNot approved, 33.7% support
Zoetis Inc.2026-05-20Shareholder Shareholder proposal to permit shareholder action by written consent.ForAGAINST — 3 of 4 JANUS INVESTMENT FUND fundsAgainst—

Download all 6 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 84.1% of this fund’s 801 such votes could be given a sector; the other 127 (15.9%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Health Care630203.2%
Industrials2700.0%
Consumer Staples1715.9%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections5120
Say-on-Pay820
Audit-related810
Compensation451
Corporate Governance4212
Capital Structure260
Extraordinary Transactions80
Other Social Issues65
Shareholder Rights and Defenses40
Environment or Climate33

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Eli Lilly and CompanyMay 4, 2026$702M102
Johnson & JohnsonApril 23, 2026$432M151
AbbVie Inc.May 8, 2026$272M81
UnitedHealth Group IncorporatedJune 1, 2026$248M121
Thermo Fisher Scientific Inc.May 20, 2026$181M130
Revolution Medicines, Inc.June 18, 2026$181M40
argenx SENovember 18, 2025$167M10
argenx SEMay 6, 2026$162M120

Notable votes against management

MeetingCompanyProposalFundMgmt
May 4, 2026Eli Lilly and CompanyShareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposalAgainstFor
May 4, 2026Eli Lilly and CompanyShareholder proposal to prepare an annual lobbying report. Shareholder proposalAgainstFor
April 23, 2026Johnson & JohnsonIndependent Board Chair Shareholder proposalForAgainst
May 8, 2026AbbVie Inc.Stockholder Proposal - to Adopt a Policy to Require an Independent Chair Shareholder proposalForAgainst
June 1, 2026UnitedHealth Group IncorporatedIf properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. Shareholder proposalForAgainst
May 13, 2026Vertex Pharmaceuticals IncorporatedShareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. Shareholder proposalAgainstFor
May 19, 2026Amgen Inc.Stockholder proposal to require an independent board chairman. Shareholder proposalForAgainst
April 23, 2026HCA Healthcare, Inc.Stockholder proposal, if properly presented at the meeting, regarding a report on healthcare consequences. Shareholder proposalAgainstFor
April 23, 2026HCA Healthcare, Inc.Stockholder proposal, if properly presented at the meeting, regarding stockholders' right to act by written consent. Shareholder proposalForAgainst
May 14, 2026CVS Health CorporationStockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. Shareholder proposalAgainstFor
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposalAgainstFor
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposalAgainstFor

Contested meetings

Meetings with a proxy contest or competing nominees (1 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

809 ballot items at 87 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Janus Henderson Global Life Sciences Fund (JAGLX) voted at 87 shareholder meetings of 83 companies, on 809 ballot items in all. Where management made a recommendation, the fund followed it on 97.4% of the items and voted against it 21 times. Its most frequent area of disagreement was corporate governance (12 of its votes against management). It voted on 21 shareholder proposals. It voted FOR the board's own proposals more often than JANUS INVESTMENT FUND's funds as a whole (98.8% against 97.2%). It voted differently from most JANUS INVESTMENT FUND funds on 6 items. 1 of its meetings was contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of JANUS INVESTMENT FUND’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.